Ratings Suprema Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
22,150 ^KRW	+0.91%		-4.11%	+6.24%

Mar. 22	Tranche Update on Suprema Inc.'s Equity Buyback Plan announced on March 21, 2023.	CI
Mar. 22	Tranche Update on Suprema Inc.'s Equity Buyback Plan announced on March 21, 2023.	CI

The company presents an interesting fundamental situation from a short-term investment perspective.

Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
The company returns high margins, thereby supporting business profitability.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 1386.07 for the 2024 fiscal year.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the past twelve months, EPS forecast has been revised upwards.

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SUPREMA INC.	+6.24%	110M		-
ORBBEC INC.	-31.91%	1.41B		-
NEXT BIOMETRICS GROUP ASA	+23.66%	82.34M	-	-
IDEX BIOMETRICS ASA	-25.54%	53.36M		-
FINGERPRINT CARDS AB	-47.67%	50.23M	-	C-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality